What do you do when a trusted path stops making sense? Alicia J. Osborne reached that crossroads after a stage four non-Hodgkin’s lymphoma diagnosis and a difficult round of chemotherapy. She chose to pause, gather second opinions, and map every credible option she could find. That search led to a light-based, non-transdermal patch designed to signal the body’s GHK-Cu copper peptide and wake up dormant stem cells—an approach first refined for Navy SEALs seeking safe, non-addictive performance support.

We walk through Alicia’s process step by step: why she tested one variable at a time, how she placed the patch at C7 or below the navel, and the routine that made it stick—12 hours on, 12 off, anchored to simple habits. The early signals were hard to ignore: deeper REM sleep within nights, a long-standing back pain easing by week three, and, at day 43, measurable changes across blood markers and CT scans, including the phrase “noticeable reduction of disease.” Along the way, we unpack the fundamentals of phototherapy, peptide signaling, and why independent, peer-reviewed, double-blind studies matter when you’re weighing complementary tools.

If you’re curious where to begin, Alicia suggests starting with X39 as the foundation, then layering support as needed: Eon for inflammation, glutathione for oxidative stress, and targeted placement near areas of discomfort. Because the patches are non-transdermal, nothing enters the bloodstream, which helps ease concerns about medication conflicts. You’ll hear practical tips for tracking progress—sleep quality, pain levels, energy, mobility, and, where possible, lab results—so you can make informed decisions without guesswork.

Ready to explore a different path to recovery and resilience? Press play, bring your questions, and consider a small, consistent step that might change how you feel day to day. If the story resonates, subscribe, share the episode with someone who needs hope, and leave a review to help more people find this resource.

Alicia Osborn
704-476-9857
WEBSITE